Atlas Trials

A Study of the Safety and Tolerability of MEDI-551 in Scleroderma

Clinical trial NCT00946699 · COMPLETED

Trial details

NCT number
NCT00946699
Sponsor
MedImmune LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Scleroderma
Start date
2010-03-01
Primary completion
2012-03-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.